II. Indications
- Antiiflammatory
- Fetal Lung Maturity in Preterm Labor
III. Mechanism
IV. Medications
- See Topical Corticosteroid
- See Intranasal Corticosteroid
- See Inhaled Beclomethasone
- Systemic Formulation
- Betamethasone (Celestone)
- Non-systemic formulations
V. Dosing: Adult
- See Intra-articular Corticosteroid
- Systemic Betamethasone (Celestone)
- Antiinflammatory: 0.5 to 0.9 mg IM or orally daily
- Preterm Labor (for Fetal Lung Maturity): 12 mg IM every 24 hours for 2 doses between 24 and 34 weeks gestation
VI. Pharmacokinetics
- High potency
- High anti-inflammatory potency
- No Mineralocorticoid Activity
- Long Half-Life (36-54 hours)
VII. Adverse Effects
VIII. Safety
- See Systemic Corticosteroid
- Avoid in Lactation
IX. Resources
- Betamethasone Injectable
X. References
- Swadron and Hope in Herbert (2018) EM:Rap 18(9):16-8
- Dvorin (2020) Am Fam Physician 101(2): 89-94 [PubMed]
- Lane (1998) Endocrinol Metab Clin North Am 27:465-83 [PubMed]